CMA green lights Balsm Alofoq’s 20% Nomu IPO

12/09/2024 Argaam
Logo of Capital Market Authority (CMA)

Logo of Capital Market Authority (CMA)

The Capital Market Authority (CMA) approved the application submitted by Balsm Alofoq Medical Co. to register and offer 20% of its 1.25 million share capital on Nomu-Parallel Market.

 

The offering will be confined to qualified investors and the prospectus will be published within the stipulated period prior to the offering, the market regulator said in a statement today, Sept. 12.

 

For More IPOs

 

The approval is valid for six months. It shall be deemed cancelled if the offering and listing are not finalized within this period.

Comments {{getCommentCount()}}

Be the first to comment

{{comment.FollowersCount}}
{{comment.CommenterComments}}

رد{{comment.DisplayName}} على {{getCommenterName(comment.ParentThreadID)}}

{{comment.DisplayName}} حساب موثّق

{{comment.ElapsedTime}}
{{comment.Replies.length}}
تعديل
loader Train
Report
loader Train
Sorry: the validity period has ended to comment on this news
Opinions expressed in the comments section do not reflect the views of Argaam. Abusive comments of any kind will be removed. Political or religious commentary will not be tolerated.